Abstract
Elevated islet uncoupling protein-2 (UCP-2) impairs β-cell function and UCP-2 may be increased in clinical obesity and diabetes. We investigated the effects of glucose and leptin on UCP-2 expression in isolated human islets. Human islets were incubated for 24 h with glucose (5.5–22 mmol/l)±leptin (0–10 nmol/l). Some islet batches were incubated at high (22 mmol/l), and subsequently lower (5.5 mmol/l), glucose to assess reversibility of effects. Leptin effects on insulin release were also measured. Glucose dose-dependently increased UCP-2 expression in all islet batches, maximally by three-fold. This was not fully reversed by subsequently reduced glucose levels. Leptin decreased UCP-2 expression by up to 75%, and maximally inhibited insulin release by 47%, at 22 mmol/l glucose. This is the first report of UCP-2 expression in human islets and provides novel evidence of its role in the loss of β-cell function in diabetes.
Original language | English |
---|---|
Pages (from-to) | 189-192 |
Number of pages | 4 |
Journal | FEBS Letters |
Volume | 513 |
Issue number | 2-3 |
Early online date | 25 Jan 2002 |
DOIs | |
Publication status | Published - 27 Feb 2002 |
Bibliographical note
Open ArchiveKeywords
- β-Cell
- gene expression
- glucose toxicity
- type 2 diabetes